Alps Advisors Inc. Sells 4,668 Shares of Phibro Animal Health Corporation (PAHC)

Alps Advisors Inc. trimmed its position in Phibro Animal Health Corporation (NASDAQ:PAHC) by 26.6% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 12,873 shares of the company’s stock after selling 4,668 shares during the period. Alps Advisors Inc.’s holdings in Phibro Animal Health Corporation were worth $477,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. State of Alaska Department of Revenue boosted its position in Phibro Animal Health Corporation by 80.9% in the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after buying an additional 1,650 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its position in Phibro Animal Health Corporation by 3.6% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the last quarter. KBC Group NV bought a new position in Phibro Animal Health Corporation in the 2nd quarter valued at $166,000. Victory Capital Management Inc. boosted its position in Phibro Animal Health Corporation by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 5,380 shares of the company’s stock valued at $199,000 after buying an additional 807 shares during the last quarter. Finally, Capital Fund Management S.A. acquired a new position in shares of Phibro Animal Health Corporation in the 2nd quarter valued at $210,000. Hedge funds and other institutional investors own 47.98% of the company’s stock.

Phibro Animal Health Corporation (NASDAQ PAHC) opened at $34.80 on Monday. The firm has a market capitalization of $1,398.37, a price-to-earnings ratio of 22.75, a PEG ratio of 4.08 and a beta of 1.35. Phibro Animal Health Corporation has a 12 month low of $26.10 and a 12 month high of $40.25. The company has a debt-to-equity ratio of 1.91, a current ratio of 3.26 and a quick ratio of 1.85.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, November 6th. The company reported $0.38 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.01. The business had revenue of $193.40 million for the quarter, compared to the consensus estimate of $189.89 million. Phibro Animal Health Corporation had a return on equity of 42.75% and a net margin of 8.87%. The firm’s revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.36 EPS. sell-side analysts forecast that Phibro Animal Health Corporation will post 1.57 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Wednesday, December 6th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 1.15%. The ex-dividend date is Tuesday, December 5th. Phibro Animal Health Corporation’s payout ratio is presently 23.53%.

A number of research analysts have recently weighed in on the company. Bank of America Corporation reissued an “underperform” rating and issued a $33.00 price target on shares of Phibro Animal Health Corporation in a research note on Wednesday, August 23rd. BidaskClub downgraded Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Credit Suisse Group increased their price target on Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a research note on Thursday, August 31st. Piper Jaffray Companies set a $42.00 price target on Phibro Animal Health Corporation and gave the company a “buy” rating in a research note on Friday, August 25th. Finally, Zacks Investment Research downgraded Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $38.25.

WARNING: “Alps Advisors Inc. Sells 4,668 Shares of Phibro Animal Health Corporation (PAHC)” was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.com-unik.info/2017/11/20/alps-advisors-inc-sells-4668-shares-of-phibro-animal-health-corporation-pahc.html.

In related news, Director Gerald K. Carlson sold 5,400 shares of the firm’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $36.27, for a total transaction of $195,858.00. Following the sale, the director now owns 5,400 shares of the company’s stock, valued at approximately $195,858. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Larry Lee Miller sold 32,459 shares of the firm’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $35.59, for a total value of $1,155,215.81. Following the sale, the chief operating officer now directly owns 4,237 shares in the company, valued at approximately $150,794.83. The disclosure for this sale can be found here. Insiders have sold a total of 279,791 shares of company stock worth $10,118,331 in the last ninety days. 51.88% of the stock is currently owned by company insiders.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

What are top analysts saying about Phibro Animal Health Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Phibro Animal Health Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit